Assignee
AMLO BIOSCIENCES LTD
GB·3 granted patents·4 pending applications·2 citations·filing 2015–2023
Top patents by PatentIndex Score
7 records- 0169US10634678B2Ambra-1 and Loricrin as biomarkers for disease progression in melanomaAMLO BIOSCIENCES LTD·Filed 2015·Granted Apr 28, 2020·2 cites·4 claims
- 0256US2025189528A1Biomarkers for disease progression and/or recurrence in squamous cell carcinomaAMLO BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 0345US2020018756A1Biomarkers for disease progression in melanomaAMLO BIOSCIENCES LTD·Filed 2019·Application pending·0 cites
- 0443US12455289B2Monoclonal antibodies against loricrinAMLO BIOSCIENCES LTD·Filed 2019·Granted Oct 28, 2025·0 cites·18 claims
- 0542US12275780B2Monoclonal antibodies against Ambra-1AMLO BIOSCIENCES LTD·Filed 2019·Granted Apr 15, 2025·0 cites·16 claims
- 0641US2022412976A1Clinical management of oropharyngeal squamous cell carcinomaAMLO BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 0738US2022308059A1Biomarkers for disease progression in squamous cell carcinomaAMLO BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMLO BIOSCIENCES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →